The relation between molecular properties of drugs and their transport across the intestinal membrane

Daru

Volumn 14, Issue 4, 2006, Pages 164-171

  Zakeri Milani, P ^a,b   Tajerzadeh, H ^c   Islambolchilar, Z ^a   Barzegar, S ^a   Valizadeh, H ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fa; Hydrogen bond; LogP; Permeability; PSA; Rotatable bond

Indexed keywords

ATENOLOL; CARBAMAZEPINE; CIMETIDINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; KETOPROFEN; METOPROLOL; NAPROXEN; PHENAZONE; PHOSPHATE BUFFERED SALINE; PIROXICAM; PROPRANOLOL; RANITIDINE;

ABSORPTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CHEMICAL BOND; DRUG TRANSPORT; FLOW RATE; HYDROGEN BOND; INTESTINE; INTESTINE MUCOSA; MALE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MOLECULAR DYNAMICS; NONHUMAN; RAT; SURFACE PROPERTY;

EID: 33846870011     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Palm K, Stenberg P, Luthman K, Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res 1997; 14(5): 568-571.
2. Hillgren KM, Borechardi RT. In vitro systems for studying intestinal drug absorption. Med Res Rev 1995; 15: 83-109.
3. Salphati L, Childers K, Pan L, Tsutsui K, Takahashi L . Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. J Pharm Pharmacol 2001; 53:1007-1013.
4. 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS Pharm Sci (http://www.pharmsci.org), 2001; 3(3).
5. Lipinsky CA, Lombardo F, Dominy RW, Feeney PJ . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997; 23: 3-25.
6. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD . Molecular properties that influence the oral bioavailability of drugs candidates. J Med Chem 2002; 45: 2615-1623.
7. Sinko PJ, Hu P, Waclawski AP, Patel NR . Oral absorption of anti-AIDS nucleoside analogues. 1. Intestinal transport of didanosine in rat and rabbit preparations. J Pharm Sci 1995; 84: 959-965.
8. Svensson USH, Sandstorm R, Carlberg O, Lennernas H, Ashton M . High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-gp involvement. Drug Metab Dispos 1999; 27: 227-232.
9. Ernest D, Alfert ED, Brenda M, Cross BM, McWilliam AA (Editors). CCAC, Guide to the care and use of experimental animals, Ottawa, Canadian Council on Animal Care, 1993; vol 1, 1-150.
10. Zakeri-Milani P, Barzegar-Jalali M, Tajerzadeh H, Azarmi Y, Valizadeh H. Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation. J Pharm Biomed Anal 2005; 39: 624-630.
11. Valizadeh H , Zakeri-Milani P, Islambulchilar Z, Tajerzadeh H. A simple and rapid HPLC method for determining Furosemide, Hydrochlorothiazide and Phenol red: Applicability to Intestinal permeability studies. J AOAC Int 2005; 89(1):1-6.
12. Dadashzadeh S, Vali AM, Rezagholi N. LC determination of Piroxicam in human plasma. J Pharm Biomed Anal 2002; 28(6): 1201-4.
13. Modamio P, Lastra CF, Maritto J, Error structure for the HPLC analysis for atenolol, metoprolol and propranolol: a useful weighting method in parameter estimation. J Pharm Biomed Anal 1998; 17: 507-13.
14. Swenson ES, William B, Malison B, Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity and reversibility. Pharm. Res.1994; 11(8): 1132-42.
15. Welling PG, Selen A, Pearson JG, Kwok F, Rogge MC, Ifan A, Marrero D, Craig WA, Johnson CA. A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures. J Biopharm Drug Dispos 1985; 6: 147-57.
16. Phillips CA, BB Michniak. Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhancers. J Pharm Sci 1995; 84: 1427-1433.
17. Fagerholm U, Johansson M, Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm Res 1996; 13: 1336-1342.
18. Komiya I, Park JY, Kamani A, Ho NFH, Higuchi WI. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int J Pharm 1980; 4: 249-262.
19. Levitt MD, Kneip JM, Levitt DG. Use of laminar flow and unstirred layer models to predict intestinal absorption in the rat. J Clin Invest 1988; 81: 1365-1369.
20. Collandar R, Barlund H. Permeabilitatsstudien an Chara ceratophylla. Acta Bot Fenn 1932; 11:1-14.
21. Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties. J Med Chem 2000; 43: 3714-3717.
22. Kasim N A, Whitehouse M, , Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon G L. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Molecular Pharmaceutics 2003; 1(1): 85-96.
23. Waterbeemd H. Intestinal permeability prediction from theory in: Oral drug absorption. New York: Marcel Decker; 2000: p. 36-39.
24. Palm K, Luthman K, Ungell AL, Strandlund G, Artursson P. Correlation of drug absorption with molecular surface properties. J Pharm Sci 1996; 85: 32-39.
25. Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J Pharm Sci 1999; 88: 807-814.
26. Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 1999; 88: 815-821.
27. Van de Waterbeemd H, Gamenisch G, Folkers G, Raevsky OA. Estimation of Caco-2 cell permeability using calculated molecular descriptors. Quant Struct Act Relat 1996; 15: 480-490.
28. Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernäs H, , Karlén A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters: A multivariate data analysis approach. J Med Chem 1998; 41: 4939-4949.
29. Kelder J, Grootenhuis PDJ, Bayada DM, Delbressine LPC, Ploemen JP. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 1999;16:1514-1519.
30. Gamenisch G, Waterbeemd H, Alsenz J, Folkers G, Estimation of permeability by passive diffusion through Caco-2 monolayers using the drugs lipophilicity and molecular weight. Eur J Pharm Sci1998; 6: 313-319.
31. Jay A, Walters WP, Murcko MA. Can we learn to distinguish between drug-like and nondrug-like molecules?. J Med Chem 1998; 41: 3314-3324.